Partners NKUA and UNAV of the ELMUMY project gave two oral presentations at the 65th Annual Meeting and Exposition of American Society of Hematology (ASH), held in San Diego, California from December 9-12, 2023, entitled:
“Low Levels of Circulating Tumor Cells Correlate with Favorable Clinical Outcome and Unique Biological Features in Newly Diagnosed Multiple Myeloma Patients"
and
"Biological and Clinical Significance of Undetectable Circulating Tumor Cells (CTCs) in Patients (Pts) with Multiple Myeloma (MM)".
These presentations examine the significance of undetectable Circulating Tumor Cells (CTCs) in Multiple Myeloma (MM) patients.